Approval · Notice of Compliance 19028 · 2017
TEVA-AZITHROMYCIN: Notice of Compliance 19028
Issued March 3, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19028
- Date
- March 3, 2017
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Product name change and revisions to product monograph and product labels
- Canadian reference product
- ZITHROMAX (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-AZITHROMYCIN | Not yet assigned | — |
Medicinal ingredients
- AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE 250 MG per TAB